After sun reversal of DNA damage: enhancing skin repair

Area of Science:

• Molecular Biology
• Dermatology
• Oncology

Background:

• UV radiation causes DNA damage, a primary driver of skin cancer.
• Genetic disorders like xeroderma pigmentosum highlight the critical role of DNA repair in preventing skin cancer.
• Elevated skin cancer rates in organ transplant patients correlate with immunosuppressive drug use, suggesting impaired DNA repair.

Purpose of the Study:

• To investigate the impact of immunosuppressive drugs and genetic variations on DNA repair capacity.
• To explore the potential of liposome-encapsulated DNA repair enzymes as a therapeutic intervention for skin cancer prevention.

Main Methods:

• Cultured epidermal cells were treated with cyclosporine A (CsA) or ascomycin to assess DNA damage repair inhibition.
• Analysis of cells with an 8-oxo-guanine glycosylase (OGG1) gene polymorphism to evaluate DNA repair sensitivity.
• Liposomal delivery of DNA repair enzymes was investigated as a countermeasure.

Main Results:

• CsA and ascomycin inhibited DNA damage removal by approximately 20% in cultured epidermal cells.
• Cells with the OGG1 variant polymorphism exhibited about 20% increased sensitivity to cytotoxic agents.
• Liposomal delivery of DNA repair enzymes effectively overcame DNA repair deficits.

Conclusions:

• Deficits in DNA repair, even less severe than in xeroderma pigmentosum, can contribute to increased cancer risk.
• Immunosuppressive drugs and specific genetic polymorphisms can impair DNA repair mechanisms.
• Topical application of DNA repair enzymes in liposomes shows potential for after-sun protection and mitigating cancer risk.